Patents by Inventor Seema Ahuja

Seema Ahuja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the preparation of ziprasidone
    Patent number: 8178674
    Abstract: The invention relates to processes for the preparation of substantially pure ziprasidone. The invention also relates to the preparation of acid addition salts of ziprasidone. More particularly, it relates to the preparation of substantially pure hydrochloride salt of ziprasidone. The invention also relates to pharmaceutical compositions that include the substantially pure ziprasidone or ziprasidone hydrochloride and use of said compositions for treating schizophrenia.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: May 15, 2012
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Mohan Prasad, Mahivir Singh Khanna, Seema Ahuja
  • PROCESS FOR THE PREPARATION OF ZIPRASIDONE
    Publication number: 20110207933
    Abstract: The invention relates to processes for the preparation of substantially pure ziprasidone. The invention also relates to the preparation of acid addition salts of ziprasidone. More particularly, it relates to the preparation of substantially pure hydrochloride salt of ziprasidone. The invention also relates to pharmaceutical compositions that include the substantially pure ziprasidone or ziprasidone hydrochloride and use of said compositions for treating schizophrenia.
    Type: Application
    Filed: May 4, 2011
    Publication date: August 25, 2011
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Yatendra KUMAR, Mohan PRASAD, Mahivir Singh KHANNA, Seema AHUJA
  • Process for the Preparation of Ziprasidone
    Publication number: 20080312254
    Abstract: The invention relates to processes for the preparation of substantially pure ziprasidone. The invention also relates to the preparation of acid addition salts of ziprasidone. More particularly, it relates to the preparation of substantially pure hydrochloride salt of ziprasidone. The invention also relates to pharmaceutical compositions that include the substantially pure ziprasidone or ziprasidone hydrochloride and use of said compositions for treating schizophrenia.
    Type: Application
    Filed: February 28, 2005
    Publication date: December 18, 2008
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Yatendra Kumar, Mohan Prasad, Mahivir Singh Khanna, Seema Ahuja
  • Process for the preparation of crystalline N-formimidoyl thienamycin monohydrate (imipenem monohydrate)
    Patent number: 7078534
    Abstract: The present invention relates to a cost effective and commercially viable process for the preparation of crystalline N-formimidoyl thienamycin monohydrate (Imipenem monohydrate) of Formula I.
    Type: Grant
    Filed: November 5, 2001
    Date of Patent: July 18, 2006
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Yatendra Kumar, Neera Tewari, Ran Chander Aryan, Bishwa Prakash Rai, Seema Ahuja
  • Dc-sign isoforms, related compositions and methods for their use in disease therapy
    Publication number: 20050221291
    Abstract: The present invention provides polypeptides of DC-SIGN 1, DC-SIGN2 and DC-SIGN3 isoforms, nucleic acids encoding these polypeptides, and methods of use in treating disease and modulating immune responses.
    Type: Application
    Filed: May 5, 2003
    Publication date: October 6, 2005
    Applicant: Board of Regents, The University of Texas System
    Inventors: Sunil Ahuja, Seema Ahuja, Srinivas Mummidi, Gabriel Catano
  • Process for the preparation of crystalline n-formimidoyl thienamycin monohydrate (imipenem monohydrate)
    Publication number: 20040054167
    Abstract: The present invention relates to a cost effective and commercially viable process for the preparation of crystalline N-formimidoyl thienamycin monohydrate (Imipenem monohydrate) of Formula I.
    Type: Application
    Filed: September 18, 2003
    Publication date: March 18, 2004
    Inventors: Yatendra Kumar, Neera Tewari, Ran Chander Aryan, Bishwa Prakash Rai, Seema Ahuja
  • CD40 ligand and CD40 agonist compositions and methods of use
    Publication number: 20030099644
    Abstract: Provided are methods and compositions using one or more CD40 agonists, such as CD40 ligands and/or agonistic anti-CD40 antibodies, to reduce or prevent cell death, or apoptosis, in bone cells. Methods of treating or preventing bone loss, including osteoporosis, as well as methods of reducing or eliminating the bone loss associated with steroid administration are particularly provided. Further disclosed are a variety of therapeutic kits and cocktails.
    Type: Application
    Filed: September 12, 2002
    Publication date: May 29, 2003
    Applicant: Board of Regents, The University of Texas System
    Inventors: Seema A. Ahuja, Lynda F. Bonewald
  • Methods of reducing bone loss with CD40 ligand
    Patent number: 6482411
    Abstract: Provided are methods and compositions using one or more CD40 agonists, such as CD40 ligands and/or agonistic anti-CD40 antibodies, to reduce or prevent cell death, or apoptosis, in bone cells. Methods of treating or preventing bone loss, including osteoporosis, as well as methods of reducing or eliminating the bone loss associated with steroid administration are particularly provided. Further disclosed are a variety of therapeutic kits and cocktails.
    Type: Grant
    Filed: August 24, 2000
    Date of Patent: November 19, 2002
    Assignee: Board of Regents, The University of Texas System
    Inventors: Seema A. Ahuja, Lynda F. Bonewald